Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Debated Unsettled Safety Issues Cancer Concerns about a possible connection between GLP-1 RAs and the development of neoplasms have spurred several investigations, especially on thyroid and pancreatic cancers due to a plausible mechanism and a large number of reports in the post-marketing phase [118, 128, 130]
Among GLP-1 analogues, lixisenatide has a unique pharmacokinetics
Even before the first oral formulations, questions arose about sustainability: analysts doubt that GLP-1 prices can stay high as competition mounts ( [34] )
Injectable segment contributed the largest market share in 2024
US$ 22.08
US$ 22.24
US$ 20.22
US$ 24.31
US$ 28.06
US$ 27.22
US$ 24.20
